Delayed Diagnosis of Nasal NK/T-Cell Lymphoma Following Rhinoplasty: A Cautionary Case Report
Journal of Otorhinolaryngology and Facial Plastic Surgery,
Vol. 10 No. 1 (2024),
13 March 2024
https://doi.org/10.22037/orlfps.v10i1.51158
Abstract
Background: Extranodal NK/T-cell lymphoma, nasal type (ENKTCL-NT) often presents with non-specific symptoms that mimic benign sinonasal conditions, leading to diagnostic delays. This challenge is amplified in post-operative patients, where symptoms can be attributed to surgical sequelae.
Case Presentation: A 43-year-old male presented with persistent nasal obstruction and discharge three months after undergoing rhinoplasty. Initial evaluation suggested post-operative inflammation. However, subsequent imaging revealed a destructive soft tissue mass with extensive bone erosion. Endoscopic biopsy and immunohistochemical analysis (positive for CD3, CD56, CD30) confirmed a diagnosis of high-grade ENKTCL-NT.
Conclusion: The patient achieved complete remission after definitive chemoradiotherapy. This case underscores that ENKTCL-NT can masquerade as routine post-surgical inflammation. Clinicians must maintain a high index of suspicion for malignancy in patients with refractory or progressive sinonasal symptoms following surgery to ensure timely diagnosis and treatment.
- Extranodal NK/T-Cell; Nasal type; Angiocentric T-Cell Lymphoma; Lethal Midline Granuloma; Sinonasal Neoplasms; Immunohistochemistry.
How to Cite
References
1. Li W. The 5th Edition of the World Health Organization Classification of Hematolymphoid Tumors. In: Li W, editor. Leukemia [Internet]. Brisbane (AU): Exon Publications; 2022 [cited 2025 Oct 21]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK586208/
2. Metgud RS, Doshi JJ, Gaurkhede S, Dongre R, Karle R. Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): A review about the terminology. J Oral Maxillofac Pathol JOMFP. 2011 Jan;15(1):96–100.
3. Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress. Front Pediatr [Internet]. 2019; Volume 7-2019. Available from: https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2019.00141
4. Rettinger G. Risks and complications in rhinoplasty. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2008 Mar 14;6:Doc08.
5. Vose J, Armitage J, Weisenburger D, International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol Off J Am Soc Clin Oncol. 2008 Sept 1;26(25):4124–30.
6. Qi S-N, Yang Y, Song Y-Q, et al. First-line non–non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153. | Blood Advances | American Society of Hematology [Internet]. [cited 2025 Nov 23]. Available from: https://ashpublications.org/bloodadvances/article/5/12/2576/476184/Qi-S-N-Yang-Y-Song-Y-Q-et-al-First-line-non
7. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making - PubMed [Internet]. [cited 2025 Nov 23]. Available from: https://pubmed.ncbi.nlm.nih.gov/32152465/
8. Qi SN, Yang Y, Zhang YJ, Huang HQ, Wang Y, He X, et al. Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study. Am J Hematol. 2020 Sept;95(9):1047–56.
9. Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016 Nov 12;66(6):443–59.
10. Liang R. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type. Br J Haematol. 2009 Oct;147(1):13–21.
11. Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress. Front Pediatr. 2019;7:141.
12. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma - PubMed [Internet]. [cited 2025 Nov 23]. Available from: https://pubmed.ncbi.nlm.nih.gov/30546078/
13. Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress. Front Pediatr. 2019 Apr 16;7:141.
14. Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress. Front Pediatr. 2019 Apr 16;7:141.
15. Harabuchi Y, Kataura A, Kobayashi K, Yamamoto T, Yamanaka N, Hirao M, et al. Lethal midline granuloma (peripheral T-cell lymphoma) after lymphomatoid papulosis. Cancer. 1992 Aug 15;70(4):835–9.
16. Miyake MM, Oliveira MVC de, Miyake MM, Garcia JO de A, Granato L. Clinical and otorhinolaryngological aspects of extranodal NK/T cell lymphoma, nasal type. Braz J Otorhinolaryngol. 2014;80(4):325–9.
17. Aozasa K, Takakuwa T, Hongyo T, Yang WI. Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol. 2008 Mar;87(2):110–7.
18. Harabuchi Y, Kataura A, Imai K. Circulating intercellular adhesion molecule-1 and its cellular expression in head and neck non-Hodgkin’s lymphomas, including lethal midline granuloma. Ann Otol Rhinol Laryngol. 1996 Aug;105(8):634–42.
19. Jeong SH. Extranodal NK/T cell lymphoma. Blood Res. 2020 July 30;55(Suppl):S63–71.
20. Tse E, Kwong YL. Diagnosis and management of extranodal NK/T cell lymphoma nasal type. Expert Rev Hematol. 2016 Sept;9(9):861–71.
21. Sánchez-Romero C, Bologna-Molina R, Paes de Almeida O, Santos-Silva AR, Prado-Ribeiro AC, Brandão TB, et al. Extranodal NK/T cell lymphoma, nasal type: An updated overview. Crit Rev Oncol Hematol. 2021 Mar;159:103237.
22. Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma | Journal of Clinical Oncology [Internet]. [cited 2025 Nov 24]. Available from: https://ascopubs.org/doi/10.1200/JCO.2005.03.2573
23. You JY, Chi KH, Yang MH, Chen CC, Ho CH, Chau WK, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol Off J Eur Soc Med Oncol. 2004 Apr;15(4):618–25.
- Abstract Viewed: 51 times
- PDF Downloaded: 36 times